| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2332 |
| Trial ID | NCT04309981 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ARI0002h |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody. |
| Year | 2020 |
| Country | Spain |
| Company sponsor | Institut d'Investigacions Biomèdiques August Pi i Sunyer |
| Other ID(s) | CARTBCMA-HCB-01|2019-001472-11 |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||